on 3 Jan 2017
Last Applicant/ Owned by
AVALANCHE BIOTECHNOLOGIES INC.
1035 O'Brien Drive, Suite BMenlo Park, CA 94025
US
Serial Number
1700514 filed on 30th Oct 2014
Correspondent Address
GOWLING WLG (CANADA) LLP
550 BURRARD STREETSUITE 2300VANCOUVER
BRITISH COLUMBIA
CA
V6C2B5
Trademark usage description
pharmaceutical preparations, namely, a drug delivery system comprising a viral vector for the delivery of a wide variety of therapeutic agents; pharma Read MoreVienna Information
2 . 9 . 4
Eyes -- Note: Including eyes with or without eyebrows and eyes with tears.Yeux -- Note: Y compris les yeux avec ou sans sourcils et les yeux avec larmes.
1 . 13 . 1
Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules
1 . 13 . 15
Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN
26 . 11 . 3
More than two lines or two bandsPlus de deux lignes ou de deux bandes
26 . 11 . 7
Vertical lines or bandsLignes ou bandes verticales
26 . 11 . 11
Broken lines or bands (except a 26.11.13)Lignes ou bandes brisées (excepté a 26.11.13)
26 . 1 . 1
CirclesCercles
26 . 1 . 3
One circle or ellipseUn cercle ou une ellipse
26 . 1 . 26
Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées
CIPO Classification Code
Nice
1700514
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 14 on 11th Oct 2016 | Default Notice Sent |
Submitted for opposition 15 on 22nd Mar 2016 | Correspondence Created |
Submitted for opposition 67 on 25th Feb 2016 | Agent Name Changed |
Submitted for opposition 68 on 25th Feb 2016 | Rep for Service Name Changed |
Submitted for opposition 15 on 28th Aug 2015 | Correspondence Created |
Submitted for opposition 22 on 14th May 2015 | Search Recorded |
Submitted for opposition 20 on 14th May 2015 | Examiner's First Report |
Submitted for opposition 31 on 3rd Nov 2014 | Formalized |
Submitted for opposition 1 on 31st Oct 2014 | Created |
Submitted for opposition 30 on 30th Oct 2014 | Filed |